Aster, Social Alpha Co-Innovation and Clinical Practice Integration Initiative

Mumbai: Aster DM Healthcare, an integrated healthcare provider and Social Alpha, an initiative supported by the Tata Trusts and Government of India; has launched Aster – Social Alpha Co-Innovation and Clinical Practice Integration Initiative. This program will support entrepreneurs and innovators working in the areas of digital health and medical technologies.

The partnership will support selected start-ups to take their solutions and technologies to market via Aster and Social Alpha’s platform and ecosystem, provide access to a shared pool of mentor network, expert connects and market access opportunities. Aster and Social Alpha will work together on co-creation of technologies and support start-ups with a vast network of pharmacies, primary care clinics and hospital expertise in India and Middle East for easy clinical adoption.

Dr Satish Prasad Rath, Chief of Innovation and Research, Aster DM Healthcare said, “The start ups need real testing environment, real data, real insights, which Aster with its comprehensive network; from pharmacy, primary care to tertiary and quaternary care can help in acceleration. We are also quiet eager to use this platform to bring forth newer innovations for COVID-19 related solutions, as a part of our organisation’s efforts to continue providing easily  accessible quality care.”

The partnership has already shortlisted three technologies for the first batch of Aster – Social Alpha Clinical Practice Integration Initiative. These technologies have been carefully identified based on the gaps in different stages of the existing Covid-19 management. These technologies include: a digital therapeutics app to manage anxiety, stress, depression and PTSD; AI driven teleICU that can reduce exposure to intensivists and care assistants and can also be used in low resource settings; and peptide based antiviral therapies targeting ACE2 and adsorption cartridges capable of removing cytokines from blood and preventing lethal complications of ARDS and viral sepsis.  

The collaboration will also include, but not be limited to, co-hosting innovation events, co-participation in grand challenges, technology and innovation evaluations, end user feedback and knowledge sharing and providing crucial mentorship support to the start-ups.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Related Articles

Leave a Reply

Back to top button